Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 2302)

Bellinzona, Canton Ticino 6500

1 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukaemia, Hematologic Malignancies, Non-Hodgkins Lymphoma, Waldenstroms Macroglobulinaemia

Studies at this site

• Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) — Recruiting now